2016 American College of Rheumatology/European League Against Rheumatism Classification Criteria for Primary Sjögren's Syndrome: A Consensus and Data-Driven Methodology Involving Three International Patient Cohorts

Arthritis and Rheumatology

Volumn 69, Issue 1, 2017, Pages 35-45

  Shiboski, Caroline H ^a   Shiboski, Stephen C ^a   Seror, Raphaèle ^b   Criswell, Lindsey A ^a   Labetoulle, Marc ^b   Lietman, Thomas M ^a   Rasmussen, Astrid ^c   Scofield, Hal ^d   Vitali, Claudio ^e,f   Bowman, Simon J ^g   Mariette, Xavier ^b   Heidenreich, A M ^h   Lanfranchi, H ^h   Vollenweider, C ^h   Schiodt M ^h   Devauchelle, V ^h   Gottenberg, J E ^h   Saraux, A ^h   Pincemin, Maggy ^h   Dorner T ^h   Tzoufias, A ^h   Baldini, C ^h   Bombardieri, S ^h   De Vita, S ^h   Kitagawa, K ^h   Sumida, T ^h   Umehara, H ^h   Bootsma, H ^h   Kruize, A A ^h   Radstake, T R ^h   Vissink, A ^h   Jonsson, R ^h   Ramos Casals, M ^h   Theander, E ^h   Challacombe, S ^h   Fisher, B ^h   Kirkham, B ^h   Larkin, G ^h   Ng, F ^h   Rauz, S ^h   Akpek, E ^h   Atkinson, J ^h   Baer, A N ^h   Carsons, S ^h   Carteron, N ^h   Daniels, T ^h   Fox, B ^h   Greenspan, J ^h   Illei, G ^h   Nelson, D ^h   Parke, A ^h   Pillemer, S ^h   Segal, B ^h   Sivils, K ^h   St Clair, E W ^h   Stone, D ^h   Vivino, F ^h   Wu, A ^h   more..

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITÉ PARIS SACLAY   (France)

^c OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

^d UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^e Istituto San Giuseppe   (Italy)

^f Casa di Cura di Lecco   (Italy)

^g UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

^h NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; IMMUNOGLOBULIN G; RHEUMATOID FACTOR;

ANTIBODY TITER; ARTICLE; CONSENSUS; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE CLASSIFICATION; EYE EXAMINATION; HUMAN; MAJOR CLINICAL STUDY; PRACTICE GUIDELINE; PRIORITY JOURNAL; SALIVARY GLAND BIOPSY; SALIVATION; SENSITIVITY AND SPECIFICITY; SEROLOGY; SIALOADENITIS; SJOEGREN SYNDROME; STAINING; VIGNETTE; CLASSIFICATION; CONSENSUS DEVELOPMENT; INFORMATION PROCESSING; INTERNATIONAL COOPERATION; SJOGREN'S SYNDROME; UNITED STATES; VALIDATION STUDY;

DATASETS AS TOPIC; HUMANS; INTERNATIONALITY; PRACTICE GUIDELINES AS TOPIC; SJOGREN'S SYNDROME; UNITED STATES;

EID: 84995752331     PISSN: 23265191     EISSN: 23265205     Source Type: Journal    
DOI: 10.1002/art.39859     Document Type: Article

References (42)

1. Bloch KJ, Buchanan WW, Wohl MJ, Bunim JJ. Sjoegren's syndrome: a clinical, pathological, and serological study of sixty-two cases. Medicine (Baltimore) 1965;44:187–231.
2. Shearn MA. Sjögren's syndrome. Philadelphia: WB Saunders; 1971.
3. Daniels TE, Silverman S Jr, Michalski JP, Greenspan JS, Sylvester RA, Talal N. The oral component of Sjögren's syndrome. Oral Surg Oral Med Oral Pathol 1975;39:875–85.
4. Ohfuji T. Sjögren's Disease Research Committee review on research reports: annual report of the Ministry of Health and Welfare. Tokyo: Japanese Ministry of Health; 1977.
5. Manthorpe R, Frost-Larsen K, Isager H, Prause JU. Sjögren's syndrome: a review with emphasis on immunological features. Allergy 1981;36:139–53.
6. Homma M, Tojo T, Akizuki M, Yamagata H. Criteria for Sjögren's syndrome in Japan. Scand J Rheumatol Suppl 1986;61:26–7.
7. Skopouli FN, Drosos AA, Papaioannou T, Moutsopoulos HM. Preliminary diagnostic criteria for Sjögren's syndrome. Scand J Rheumatol Suppl 1986;61:22–5.
8. Fox RI, Robinson CA, Curd JG, Kozin F, Howell FV. Sjögren's syndrome: proposed criteria for classification. Arthritis Rheum 1986;29:577–85.
9. Vitali C, Bombardieri S, Moutsopoulos HM, Balestrieri G, Bencivelli W, Bernstein RM, et al. Preliminary criteria for the classification of Sjögren's syndrome: results of a prospective concerted action supported by the European Community. Arthritis Rheum 1993;36:340–7.
10. Fujibayashi T, Sugai S, Miyasaka N, Hayashi Y, Tsubota K. Revised Japanese criteria for Sjögren's syndrome (1999): availability and validity. Mod Rheumatol 2004;14:425–34.
11. Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, et al. Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002;61:554–8.
12. Shiboski SC, Shiboski CH, Criswell LA, Baer AN, Challacombe S, Lanfranchi H, et al. American College of Rheumatology classification criteria for Sjögren's syndrome: a data-driven, expert consensus approach in the Sjögren's International Collaborative Clinical Alliance cohort. Arthritis Care Res (Hoboken) 2012;64:475–87.
13. Rasmussen A, Ice JA, Li H, Grundahl K, Kelly JA, Radfar L, et al. Comparison of the American-European Consensus Group Sjögren's syndrome classification criteria to newly proposed American College of Rheumatology criteria in a large, carefully characterised sicca cohort. Ann Rheum Dis 2014;73:31–8.
14. Seror R, Gottenberg JE, Devauchelle-Pensec V, Dubost JJ, le Guern V, Hayem G, et al. European League Against Rheumatism Sjögren's Syndrome Disease Activity Index and European League Against Rheumatism Sjögren's Syndrome Patient-Reported Index: a complete picture of primary Sjögren's syndrome patients. Arthritis Care Res (Hoboken) 2013;65:1358–64.
15. Seror R, Mariette X, Bowman S, Baron G, Gottenberg JE, Bootsma H, et al. Accurate detection of changes in disease activity in primary Sjögren's syndrome by the European League Against Rheumatism Sjögren's Syndrome Disease Activity Index. Arthritis Care Res (Hoboken) 2010;62:551–8.
16. Seror R, Ravaud P, Bowman SJ, Baron G, Tzioufas A, Theander E, et al. EULAR Sjögren's Syndrome Disease Activity Index: development of a consensus systemic disease activity index for primary Sjögren's syndrome. Ann Rheum Dis 2010;69:1103–9.
17. Seror R, Ravaud P, Mariette X, Bootsma H, Theander E, Hansen A, et al. EULAR Sjögren's Syndrome Patient Reported Index (ESSPRI): development of a consensus patient index for primary Sjögren's syndrome. Ann Rheum Dis 2011;70:968–72.
18. Bowman SJ, Fox RI. Classification criteria for Sjögren's syndrome: nothing ever stands still! Ann Rheum Dis 2014;73:1–2.
19. Classification and Response Criteria Subcommittee of the American College of Rheumatology Committee on Quality Measures. Development of classification and response criteria for rheumatic diseases. Arthritis Rheum 2006;55:348–52.
20. Dougados M, Gossec L. Classification criteria for rheumatic diseases: why and how? Arthritis Rheum 2007;57:1112–5.
21. Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO III, et al. 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Ann Rheum Dis 2010;69:1580–8.
22. Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO III, et al. 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum 2010;62:2569–81.
23. Van den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A, et al. 2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum 2013;65:2737–47.
24. Van den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A, et al. 2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Ann Rheum Dis 2013;72:1747–55.
25. Hansen P, Ombler F. A new method for scoring multi-attribute value models using pairwise rankings of alternatives. J Multi-Crit Decis Anal 2008;15:87–107.
26. Van Bijsterveld OP. Diagnostic tests in the Sicca syndrome. Arch Ophthalmol 1969;82:10–4.
27. Whitcher JP, Shiboski CH, Shiboski SC, Heidenreich AM, Kitagawa K, Zhang S, et al. A simplified quantitative method for assessing keratoconjunctivitis sicca from the Sjögren's Syndrome International Registry. Am J Ophthalmol 2010;149:405–15.
28. Minds. URL1000: https://www.1000minds.com/solutions/decision-making-software.
29. Neogi T, Aletaha D, Silman AJ, Naden RL, Felson DT, Aggarwal R, et al. The 2010 American College of Rheumatology/European League Against Rheumatism classification criteria for rheumatoid arthritis: phase 2 methodological report. Arthritis Rheum 2010;62:2582–91.
30. Daniels TE, Cox D, Shiboski CH, Schiodt M, Wu A, Lanfranchi H, et al. Associations between salivary gland histopathologic diagnoses and phenotypic features of Sjögren's syndrome among 1,726 registry participants. Arthritis Rheum 2011;63:2021–30.
31. Navazesh M. Methods for collecting saliva. Ann N Y Acad Sci 1993;694:72–7.
32. Navazesh M, Kumar SK, University of Southern California School of Dentistry. Measuring salivary flow: challenges and opportunities. J Am Dent Assoc 2008;139 Suppl:35S–40S.
33. R Project. URL: http://www.R-project.org.
34. Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap): a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 2009;42:377–81.
35. Strobl C, Boulesteix AL, Kneib T, Augustin T, Zeileis A. Conditional variable importance for random forests. BMC Bioinformatics 2008;9:307.
36. Schisterman EF, Perkins NJ, Liu A, Bondell H. Optimal cut-point and its corresponding Youden Index to discriminate individuals using pooled blood samples. Epidemiology 2005;16:73–81.
37. Sullivan LM, Massaro JM, D'Agostino RB Sr. Presentation of multivariate data for clinical use: the Framingham Study risk score functions. Stat Med 2004;23:1631–60.
38. Baer AN, McAdams DeMarco M, Shiboski SC, Lam MY, Challacombe S, Daniels TE, et al. The SSB-positive/SSA-negative antibody profile is not associated with key phenotypic features of Sjögren's syndrome. Ann Rheum Dis 2015;74:1557–61.
39. Defendenti C, Atzeni F, Spina MF, Grosso S, Cereda A, Guercilena G, et al. Clinical and laboratory aspects of Ro/SSA-52 autoantibodies. Autoimmun Rev 2011;10:150–4.
40. Dugar M, Cox S, Limaye V, Gordon TP, Roberts-Thomson PJ. Diagnostic utility of anti-Ro52 detection in systemic autoimmunity. Postgrad Med J 2010;86:79–82.
41. Ghillani P, Andre C, Toly C, Rouquette AM, Bengoufa D, Nicaise P, et al. Clinical significance of anti-Ro52 (TRIM21) antibodies non-associated with anti-SSA 60kDa antibodies: results of a multicentric study. Autoimmun Rev 2011;10:509–13.
42. Menendez A, Gomez J, Escanlar E, Caminal-Montero L, Mozo L. Clinical associations of anti–SSA/Ro60 and anti-Ro52/TRIM21 antibodies: diagnostic utility of their separate detection. Autoimmunity 2013;46:32–9.